NCT06237205 2024-02-01
Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination Deficiency
Korea University Anam Hospital
Phase 2 Not yet recruiting
Clinical Trials
3 trialsNCT05993455 2023-08-15
A Phase 2 Basket Trial in Which Patients With Advanced Solid Tumors Carrying the KRAS G12C mUtation Receive Treatment With a Combination of Sotorasib and Panitumumab
Korea University Anam Hospital
Phase 2 Unknown
NCT05325684 2022-04-13
PD-L1 Inhibitor Rechallenge After PD-1 Immunotherapy for Patients With Solid Tumor Beyond Lung Cancer
The Affiliated Hospital of Qingdao University
Phase 1/2 Unknown